PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyDung T. Le, Luis A. Díaz, Nilofer S. Azad et al.|New England Journal of Medicine|2015Cited by 9.4k
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeDung T. Le, Luis A. Díaz, Jennifer N. Durham et al.|Science|2017Cited by 6.6k
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice GuidelinesGeorge D. Demetri, John Zalcberg, Robert S. Benjamin et al.|Journal of the National Comprehensive Cancer Network|2007Cited by 636
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced CancersBranimir I. Šikić, Sukhmani K. Padda, Nehal J. Lakhani et al.|Journal of Clinical Oncology|2019Cited by 590
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen Hege, Stephen A. Sherwin, Emily K. Bergsland et al.|Journal for ImmunoTherapy of Cancer|2017Cited by 320